Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Therapy of Calcipotriol/Betamethasone and Calcipotriol in Psoriasis Vulgaris
NCT02191007Completed
- Sponsor
- Xijing Hospital
- Start
- Nov 2013
- Primary completion
- May 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, single-blind trial of AKP01 and betamethasone dipropionate spray 0.05% in Psoriasis vulgaris (PV), sponsored by Xijing Hospital. Started Nov 2013; status: completed.
02
Drugs
AKP01betamethasone dipropionate spray 0.05%
03
Conditions
Psoriasis vulgaris (PV)
Beyond the preview
Go deeper on NCT02191007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02191007.